<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00821275</url>
  </required_header>
  <id_info>
    <org_study_id>2007026</org_study_id>
    <nct_id>NCT00821275</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma</brief_title>
  <official_title>Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficacy and safety of uterine artery embolization, as compared with standard surgical
      methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of
      this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief,
      complication, fertility, ovarian function and quality of life with uterine artery
      embolization for uterine fibroids comparing with standard surgical methods.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>quality of life</measure>
    <time_frame>1,3,5,10 year.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>pregnant</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>tumor recurrence</measure>
    <time_frame>1,3,5,10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>3,6,12,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ovarian functions</measure>
    <time_frame>3,6,12 months, 2,3,5 and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom relief</measure>
    <time_frame>3,6,12,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumour volume</measure>
    <time_frame>3,6,12 18 24 months and 3,5,10 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Leiomyoma</condition>
  <arm_group>
    <arm_group_label>pregnancy expectation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients who desire for future pregnancy will enroll into this arm , and will be divided into UAE group and SURGERY group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No pregnancy expectation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients who don't desire for reserving uterus and/ or future pregnancy will enroll into this arm , and will be divided into UAE group and SURGERY group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Interventional radiological or surgical management</intervention_name>
    <description>Uterine artery embolization will be done for the patients who enroll into UAE group and desire for future pregancy and reserving uterus.Myomectomy will be performed for the patients who enroll into SURGERY group and desire for future pregancy and reserving uterus.Hysterectomy will be done for the patients who enroll into SURGERY group and don't desire for reserving uterus and/or future pregnancy.</description>
    <arm_group_label>pregnancy expectation</arm_group_label>
    <arm_group_label>No pregnancy expectation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of symptomatic uterine leiomyoma

        Exclusion Criteria:

          -  pregnancy

          -  iodine agent allergy

          -  patient refuse to take part in this trial

          -  tumour size is less than 3cm or beyond 10cm

          -  with endometriosis

          -  with malignant diseases

          -  with abnormal coagulation function which can't restore

          -  with acute inflammatory diseases or acute episode of chronic inflammatory diseases

          -  with severe heart, lung, liver and kidney, et al. organ diseases.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Shan, M.D., PHD.</last_name>
    <role>Study Director</role>
    <affiliation>Third Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanfang Hospital of Nanfang medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>the first Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510089</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.zssy.com.cn/</url>
    <description>The Third Affiliated Hospital of Sun Yat-sen University</description>
  </link>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2009</study_first_submitted>
  <study_first_submitted_qc>January 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2009</study_first_posted>
  <last_update_submitted>January 9, 2009</last_update_submitted>
  <last_update_submitted_qc>January 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Hong Shan</name_title>
    <organization>the third Affiliated Hospital of Sun Yat-sen University</organization>
  </responsible_party>
  <keyword>Uterine Artery Embolization</keyword>
  <keyword>Leiomyoma</keyword>
  <keyword>myomectomy</keyword>
  <keyword>hysterectomy</keyword>
  <keyword>pregnancy</keyword>
  <keyword>complication</keyword>
  <keyword>ovarian function</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

